Eggy burps and diarrhoea on Mounjaro: why they happen and what you can do

Sulphur-smelling belching and loose stools are a known GI effect of tirzepatide, most common at the start of treatment and after dose increases.
Slowed gastric emptying is the main mechanism: food and gas move through the gut more slowly, producing fermentation-related odours.
Most cases are self-limiting; staying well hydrated and adjusting meal size and composition can reduce severity.
Severe, persistent stomach pain — especially pain that radiates towards the back — needs prompt medical attention; report unexpected side effects via the MHRA Yellow Card scheme.

Eggy burps and diarrhoea are among the most reported gastrointestinal side effects of Mounjaro (tirzepatide). They tend to peak in the first few days after starting or increasing a dose, and for most people they settle within a week or two as the body adjusts. You're not imagining it, and you're not alone. Mounjaro is a prescription-only medicine, so any concerns about how your body is responding should go to your prescriber rather than being managed in isolation. The NHS medicines page for tirzepatide lists gastrointestinal effects as the most commonly reported side effects across the clinical programme.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding, managing and knowing when to act on Mounjaro's eggy-burp and diarrhoea symptoms

It's your third day on 2.5mg and the burps have arrived uninvited

You picked up your Mounjaro pen, noted its DPD tracking number, and gave yourself the first injection without drama. A few days later, the eggy burps started. Then loose stools. This is, frustratingly, a very common experience in the first one to two weeks of tirzepatide, not a sign that something has gone wrong, and not a reason to panic.

The mechanism is straightforward. Mounjaro slows the rate at which the stomach empties, which is partly how it reduces appetite. That slower transit means food (particularly high-protein and high-sulphur foods like eggs, red meat, cruciferous vegetables and onions) ferments for longer in the gut. The gas produced contains hydrogen sulphide, which is why the burps smell the way they do. The same delayed gastric emptying can shift fluid balance in the bowel and produce looser stools. For more detail on how this specific symptom cluster develops, the page on eggy burps on Mounjaro covers the mechanism in full.

Diarrhoea tends to be more common early in treatment or after a dose step-up. It's usually mild to moderate and resolves on its own. The clinical trials consistently showed GI effects were the most frequently reported side effects, most pronounced in the early weeks. If you're finding that sulphur burps and diarrhea are arriving together on Mounjaro, that combination is well documented and there are practical ways to manage it. Knowing that doesn't make it feel better on day three, but it does mean you have a reasonable basis for watching and waiting rather than immediately stopping treatment.

What actually makes a difference: practical adjustments that are worth trying

Small meals help more than almost anything else. Tirzepatide slows gastric emptying, so a large meal sits in the stomach longer and ferments more. Eating to 80% full (stopping before you feel stuffed) reduces both the belching and the downstream GI disruption. Eating slowly matters for the same reason.

Cutting back temporarily on the highest-offending foods can reduce the sulphur-burp intensity significantly. Eggs, garlic, onions, broccoli, cauliflower and red meat are all high in sulphur compounds; they're not bad foods, but during the adjustment period reducing portion sizes can make a noticeable difference. Reintroducing them gradually once the GI symptoms settle is usually fine.

Hydration is critical, especially if diarrhoea is present. Loose stools deplete fluid and electrolytes faster than most people realise. Water, diluted squash, and foods with high water content all count. Alcohol and carbonated drinks tend to worsen both symptoms and are worth avoiding in the early weeks.

If you're dealing with the combination of sulfur burps and diarrhea on Mounjaro, that page goes further on dietary strategies. If symptoms are making everyday life difficult, speak to your prescriber, there may be clinical reasons to slow the titration schedule rather than push through.

When to get medical help rather than wait it out

Most eggy burps and loose stools on Mounjaro are unpleasant but not dangerous. There are specific situations, though, where you should contact a doctor or call 111 promptly rather than managing at home.

Severe stomach pain (particularly pain that is persistent and radiates towards your back, with or without vomiting) should not be attributed to ordinary GI upset. In January 2026, the MHRA issued a Drug Safety Update specifically flagging acute pancreatitis as an infrequent but serious known risk with GLP-1 medicines; the MHRA Drug Safety Update series contains the full communication. Pancreatitis requires prompt medical assessment. More on protecting your digestive health during treatment is covered on the page about pancreas care on Mounjaro.

You should also seek medical help if diarrhoea is severe enough to prevent you from keeping fluids down, if you develop signs of dehydration (dizziness, reduced urination, dry mouth), or if symptoms persist for more than two weeks without any improvement.

Any suspected side effect (even one that seems minor) can be reported directly by patients and carers via the Yellow Card scheme. Reports help the MHRA monitor the safety of medicines in real-world use. It takes about ten minutes and you don't need a GP's help to submit one.

How a clinical prescriber approaches these symptoms before and during treatment

Eggy burps and diarrhoea are common enough that a thorough prescriber will often mention them before the first pen is used, not to alarm, but so patients know what to watch for versus what needs attention. At nume, every consultation is reviewed personally by a GPhC-registered prescriber, not processed by an algorithm. That means your full health picture is seen before treatment starts, including factors that might make GI side effects more likely or severe.

The broader side-effect profile of tirzepatide, including the full list of GI effects, is covered on the Mounjaro side effects page. If you're still at the research stage, the Mounjaro overview covers how the medicine works, what it's licensed for in the UK, and what the clinical evidence shows. For those ready to discuss suitability, the free consultation is the place to start, side effects, your medical history and how to reduce early GI symptoms are all part of the conversation, not afterthoughts.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions